The immunoreactivity of haemagglutinin (HA) polypeptides of equine influenza virus was compared among the strains isolated in Poland, using H3 monoclonal antibody. A stronger signal in immunoblot reaction was observed for A/equi/Pulawy/2008 HA polypeptides compared to A/equi/Pulawy/2006, despite the fact that both strains are phylogenetically closely related and belong to Florida clade 2 of American lineage. The strongest signal, observed in the case of A/equi/Pulawy/2008, seemed to be connected with the presence of G135, I213, E379, and/or V530 instead of R135, M213, G379, and I530 present in A/equi/Pulawy/2006 HA sequence. This implies that point mutations within amino acid sequences of HA polypeptides of equine influenza virus may change their immunoreactivity even when they are not located within five basic antigenic sites.
Introduction
The haemagglutinin (HA), a surface glycoprotein of influenza virus, is synthesised as a precursor HA0, which is proteolytically cleaved into two subunits: HA1 and HA2. The HA is responsible for binding virions to sialic acid containing cell surface receptors mediating fusion of viral and cellular membranes (6, 7, 8) . The analysis of HA structure defined five antigenic sites. Amino acid changes occurring either in the antigenic sites or adjacent positions may affect antibody recognition. Equine influenza virus (EIV) undergoes antigenic drift and it is suggested that even one or two substitutions in key sites may be sufficient to cause antigenic changes (3). We would like to report the unusual pattern of HA reactivity of three Polish EIV isolates with the monoclonal antibody for H3 serotype. The viruses were isolated from horses in three different studs. At isolation time, mild clinical signs were observed. However, since the time of isolation we have monitored the clinical status of horses in these studs and have not found any further symptoms of respiratory diseases to date. It seems that the reactions observed do not influence the pathogenic properties of the strains. were multiplicated in embryonated chicken eggs. Virions were purified from allantoic fluids showing HA titre above 64 by ultracentrifugation through glycerol layer as described previously (4) . Protein concentration was determined using DC Protein Assay (Bio Rad) according to manufacturer's instructions.
Material and Methods

Purification
Electrophoresis and western blot analysis. SDS PAGE in 15% polyacrylamide gel under reducing or non-reducing conditions (+DTT, -DTT) and western blot were performed as described previously (2) . An amount of 5 µg of viral proteins was used for electrophoretic and western blot analysis. Two monoclonal antibodies were used: a haemagglutinin H3 mouse monoclonal antibody (InA227, Novus Biologicals) and a mouse monoclonal anti influenza A matrix protein (MCA401 AbD Serotec).
Sequence analysis. Amino acid sequences translated from full length HA genes of A/equi/Pulawy/2005 (GenBank Ac. no GU066395), A/equi/Pulawy/2006 (GenBank Ac. no GU066396) (5), and A/equi/Pulawy/2008 (GenBank Ac. no KT429521) were aligned against A/Shangdong/9/93 (immunogen used for InA227 antibody preparation, GenBank Ac. no ACL12129) using BioEdit software (Ibis Pharmaceuticals Inc.). The authors noted differences in positions 159, 189, 227, and in at least eight other amino acids, affecting the antigenic sites. The authors also observed that I213V substitution was characteristic for Euroasian lineage, without influence on HA antigenicity. Generally, recent reports have postulated that substitutions within regions adjacent to antigenic sites may be significant for antigenic changes. Point mutations within sequences of immunologically important proteins, such as haemagglutinin of equine influenza virus, may change their immunoreactivity even when they are not located within wellcharacterised antigenic sites. Such changes, influencing protein conformation, may be located throughout the whole HA sequence. Changes in conformational and nonlinear epitopes on the protein surface or in antigen spacing result in weaker or even lack of antibody binding.
Results
Western blot analysis of
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